LP Profile

Samsung Biologics

Also known as samsung biologics

Corporate InvestorIncheon, South KoreaFounded 2011
$9.1B
Assets Under Management
Incheon
Headquarters
Investment Focus

About Samsung Biologics

Samsung Biologics is a corporate investor based in Incheon, South Korea. Founded in 2011. Reported AUM: 9052 USD millions.

Preferred Investment Types

Early StageEarly Stage: SeedEarly Stage: Start-upExpansion / Late StageVenture (General)

Preferred Sectors & Themes

BiotechnologyHealthcarePharmaceuticals

Preferred Geographies

AsiaEast and Southeast AsiaEmerging MarketsNorth AmericaOECD
Explore

Explore similar limited partners

Browse more corporate investors and other institutional investors by location and type in the LPbacked limited-partner database.

FAQ

Frequently asked questions

What type of investor is Samsung Biologics?

Samsung Biologics is a corporate investor based in Incheon, South Korea, managing approximately $9.1B in assets.

Where is Samsung Biologics headquartered?

Samsung Biologics is headquartered in Incheon, South Korea.

How much does Samsung Biologics manage?

Samsung Biologics manages approximately $9.1B in assets under management.

When was Samsung Biologics founded?

Samsung Biologics was founded in 2011.

What does Samsung Biologics invest in?

Samsung Biologics focuses on Early Stage, Early Stage: Seed, Early Stage: Start-up, Expansion / Late Stage, Venture (General), Biotechnology, Healthcare, Pharmaceuticals.

How can I contact Samsung Biologics?

Verified contact details, key decision-makers, and investment preferences for Samsung Biologics are available on LPbacked. Create a free account to access them.